Total Payments
$399.68
2021 Payments
$87.06
Companies
7
Transactions
20
Medicare Patients
61,473
Medicare Billing
$6.8M
Payment Breakdown by Category
Food & Beverage$300.68 (75.2%)
Education$99.00 (24.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $300.68 | 19 | 75.2% |
| Education | $99.00 | 1 | 24.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $120.25 | 8 | $0 (2020) |
| Kite Pharma, Inc. | $102.63 | 6 | $0 (2021) |
| Amgen Inc. | $99.00 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $38.42 | 2 | $0 (2018) |
| Epizyme, Inc., | $14.74 | 1 | $0 (2021) |
| Spectrum Pharmaceuticals Inc. | $13.39 | 1 | $0 (2017) |
| Kyowa Kirin, Inc. | $11.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $87.06 | 5 | Kite Pharma, Inc. ($72.32) |
| 2020 | $41.99 | 3 | Kite Pharma, Inc. ($30.31) |
| 2019 | $42.32 | 3 | Novartis Pharmaceuticals Corporation ($31.07) |
| 2018 | $99.30 | 6 | Novartis Pharmaceuticals Corporation ($60.88) |
| 2017 | $129.01 | 3 | Amgen Inc. ($99.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.68 | General |
| 06/22/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $19.87 | General |
| 05/07/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.28 | General |
| 02/22/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 11/04/2020 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: ONCOLOGY | ||||||
| 11/03/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $14.54 | General |
| 08/31/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $15.77 | General |
| 07/09/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2019 | Kyowa Kirin, Inc. | SANCUSO (Drug), POTELIGEO | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: ANTIEMETIC - 5HT3 INHIBITOR | ||||||
| 11/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2018 | Novartis Pharmaceuticals Corporation | RECLAST (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: BONE | ||||||
| 02/26/2018 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: HEMATOLOGY | ||||||
| 01/31/2018 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: HEMATOLOGY | ||||||
| 10/31/2017 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: HEMATOLOGY | ||||||
| 10/25/2017 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Not Applicable | ||||||
| 05/09/2017 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 87 | 14,016 | 122,785 | $6.1M | $1.1M |
| 2022 | 111 | 17,034 | 282,896 | $11.1M | $2.1M |
| 2021 | 98 | 16,851 | 304,028 | $12.2M | $2.2M |
| 2020 | 89 | 13,572 | 147,034 | $8.4M | $1.4M |
Total Patients
61,473
Total Services
856,743
Medicare Billing
$6.8M
Procedure Codes
385
All Medicare Procedures & Services
385 procedure records from CMS Medicare Utilization — Page 13 of 16
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2020 | 11 | 3,000 | $244,000 | $120,658 | 49.5% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2020 | 24 | 23,500 | $470,000 | $69,563 | 14.8% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 254 | 1,655 | $121,770 | $62,576 | 51.4% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2020 | 42 | 39,750 | $238,500 | $34,509 | 14.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 651 | 2,470 | $123,500 | $25,793 | 20.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 73 | 180 | $99,000 | $24,898 | 25.1% |
| 82306 | Vitamin d-3 level | Office | 2020 | 377 | 790 | $118,500 | $23,071 | 19.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 174 | 238 | $90,440 | $23,025 | 25.5% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2020 | 34 | 83 | $124,500 | $22,175 | 17.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 711 | 2,843 | $258,130 | $21,723 | 8.4% |
| 88184 | Flow cytometry technique for dna or cell analysis | Office | 2020 | 198 | 310 | $93,000 | $20,128 | 21.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 487 | 1,161 | $174,150 | $19,348 | 11.1% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2020 | 301 | 2,058 | $257,250 | $18,964 | 7.4% |
| 82728 | Ferritin (blood protein) level | Office | 2020 | 549 | 1,378 | $206,700 | $18,556 | 9.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 496 | 1,123 | $112,300 | $16,746 | 14.9% |
| 82746 | Folic acid level | Office | 2020 | 491 | 1,089 | $174,240 | $15,830 | 9.1% |
| 83735 | Magnesium level | Office | 2020 | 602 | 2,272 | $170,400 | $15,051 | 8.8% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2020 | 225 | 788 | $47,280 | $14,743 | 31.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 76 | 76 | $59,280 | $14,596 | 24.6% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2020 | 601 | 2,239 | $156,730 | $13,368 | 8.5% |
| 86334 | Immunologic analysis technique on serum | Office | 2020 | 281 | 592 | $148,000 | $13,100 | 8.9% |
| 83550 | Iron binding capacity | Office | 2020 | 546 | 1,370 | $171,250 | $11,830 | 6.9% |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Office | 2020 | 15 | 14,400 | $144,000 | $10,689 | 7.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 144 | $43,200 | $10,267 | 23.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 84 | 139 | $69,500 | $9,701 | 14.0% |
About Dr. Gurmohan Syali, MD
Dr. Gurmohan Syali, MD is a Medical Oncology healthcare provider based in E Setauket, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932195138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gurmohan Syali, MD has received a total of $399.68 in payments from pharmaceutical and medical device companies, with $87.06 received in 2021. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($300.68).
As a Medicare-enrolled provider, Syali has provided services to 61,473 Medicare beneficiaries, totaling 856,743 services with total Medicare billing of $6.8M. Data is available for 4 years (2020–2023), covering 385 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location E Setauket, NY
- Active Since 09/22/2005
- Last Updated 03/24/2014
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1932195138
Products in Payments
- XARELTO (Drug) $38.42
- RYDAPT (Drug) $36.13
- KISQALI (Drug) $30.64
- JADENU (Drug) $16.16
- TAZVERIK (Drug) $14.74
- Zevalin (Drug) $13.39
- PROMACTA (Drug) $13.34
- RECLAST (Drug) $12.30
- PIQRAY (Drug) $11.68
- SANCUSO (Drug) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.